Related references
Note: Only part of the references are listed.Effects of short-term chemical ablation of glucagon signalling by peptide-based glucagon receptor antagonists on insulin secretion and glucose homeostasis in mice
Zara J. Franklin et al.
BIOLOGICAL CHEMISTRY (2014)
Progressive change of intra-islet GLP-1 production during diabetes development
Thomas J. O'Malley et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Role of Endogenous GLP-1 and GIP in Beta Cell Compensatory Responses to Insulin Resistance and Cellular Stress
Srividya Vasu et al.
PLOS ONE (2014)
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice
Nigel Irwin et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
Jeff Unger
CURRENT DIABETES REPORTS (2013)
Enteroendocrine hormone mimetics for the treatment of obesity and diabetes
Nigel Irwin et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
Daniel J. Drucker
DIABETES (2013)
Alterations of Glucose-Dependent Insulinotropic Polypeptide and Expression of Genes Involved in Mammary Gland and Adipose Tissue Lipid Metabolism during Pregnancy and Lactation
R. Charlotte Moffett et al.
PLOS ONE (2013)
Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats
Tiffany Schwasinger-Schmidt et al.
PHARMACOLOGICAL RESEARCH (2013)
Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes
N. Irwin et al.
DIABETOLOGIA (2012)
In Vitro Proliferation of Adult Human Beta-Cells
Sabine Rutti et al.
PLOS ONE (2012)
Role of islet structure and cellular interactions in the control of insulin secretion
Catriona Kelly et al.
ISLETS (2011)
Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Pancreatic Islet α-Cells and Promotes Insulin Secretion
Yukihiro Fujita et al.
GASTROENTEROLOGY (2010)
Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of β-cell regeneration
German Kilimnik et al.
ISLETS (2010)
Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells
Sabine Ruetti et al.
ENDOCRINOLOGY (2009)
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
David Russell-Jones
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
Paula L. McClean et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Alpha cell function in health and disease: influence of glucagon-like peptide-1
BE Dunning et al.
DIABETOLOGIA (2005)
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine
K Mortensen et al.
REGULATORY PEPTIDES (2003)
The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice
B Rolin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)